Viome Life Sciences and Scripps Research have launched a collaboration to develop an at-home RNA screening test aimed at early detection of precancerous colon polyps. The initiative involves a 1,000-patient observational clinical study beginning this summer, collecting stool and saliva samples pre-colonoscopy to identify gene expression profiles linked to polyps. The approach leverages unbiased RNA sequencing and AI-driven biomarker identification. Success in clinical validation may lead Viome to introduce a laboratory-developed test for colon cancer risk assessment accessible through licensed physicians. Plans include publishing study findings and potentially pursuing FDA approval to establish the test as a colorectal cancer prevention standard.